Title : SL65.0155, A Novel 5-Hydroxytryptamine(4) Receptor Partial Agonist with Potent Cognition-Enhancing Properties - Moser_2002_J.Pharmacol.Exp.Ther_302_731 |
Author(s) : Moser PC , Bergis OE , Jegham S , Lochead A , Duconseille E , Terranova JP , Caille D , Berque-Bestel I , Lezoualc'h F , Fischmeister R , Dumuis A , Bockaert J , George P , Soubrie P , Scatton B |
Ref : Journal of Pharmacology & Experimental Therapeutics , 302 :731 , 2002 |
Abstract : Moser_2002_J.Pharmacol.Exp.Ther_302_731 |
ESTHER : Moser_2002_J.Pharmacol.Exp.Ther_302_731 |
PubMedSearch : Moser_2002_J.Pharmacol.Exp.Ther_302_731 |
PubMedID: 12130738 |
Moser PC, Bergis OE, Jegham S, Lochead A, Duconseille E, Terranova JP, Caille D, Berque-Bestel I, Lezoualc'h F, Fischmeister R, Dumuis A, Bockaert J, George P, Soubrie P, Scatton B (2002)
SL65.0155, A Novel 5-Hydroxytryptamine(4) Receptor Partial Agonist with Potent Cognition-Enhancing Properties
Journal of Pharmacology & Experimental Therapeutics
302 :731
Moser PC, Bergis OE, Jegham S, Lochead A, Duconseille E, Terranova JP, Caille D, Berque-Bestel I, Lezoualc'h F, Fischmeister R, Dumuis A, Bockaert J, George P, Soubrie P, Scatton B (2002)
Journal of Pharmacology & Experimental Therapeutics
302 :731